Showing results (111-120 of 497) with videos related to

Sort By:
Pageof 50
Cancer Treatment Reviews|July 13, 2024
Peripheral T-cell lymphoma: From biology to practice to the futureOwen A O'Connor, Helen Ma, Jason Yong Sheng Chan, et al.
Blood Research|October 19, 2017
Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphomaHyun-Young Kim, Mi-Ae Jang, Hee-Jin Kim, et al.
Annals of Hematology|April 9, 2018
Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphomaJinhyun Cho, Seok Jin Kim, Silvia Park, et al.
The Korean Journal of Internal Medicine|March 18, 2026
Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphomaChanggon Kim, Sang Eun Yoon, Hyun-Young Kim, et al.
Scientific Reports|May 15, 2021
EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphomaJi Yun Lee, Joo Hyun Kim, Heejin Bang, et al.
Thrombosis Research|April 18, 2012
Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian populationLee Chun Park, Sook-young Woo, Seonwoo Kim, et al.
Annals of Hematology|November 19, 2013
DCEP for relapsed or refractory multiple myeloma after therapy with novel agentsSilvia Park, Su Jin Lee, Chul Won Jung, et al.
Japanese Journal of Clinical Oncology|October 4, 2017
Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapyJun Su Park, Do Hoon Lim, Yong Chan Ahn, et al.
Transplantation and Cellular Therapy|January 7, 2023
Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin LymphomaDok Hyun Yoon, Youngil Koh, Miyoung Jung, et al.
EMBO Reports|February 29, 2012
DeSUMOylating isopeptidase: a second class of SUMO proteaseEun Ju Shin, Hyun Mi Shin, Eori Nam, et al.
Pageof 50